1-13 of 13
Michael B. Moller, MD, DMSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis

Karen Dybkær, Martin Bøgsted, Steffen Falgreen, MSc, PhD, Malene Krag Kjeldsen, Alexander Schmitz, Julie Støve Bødker, MSc, PhD, Anders Ellern Bilgrau, Zijun Y. Xu-Monette, PhD, Li Ling, Kim Steve Bergkvist, Maria Bach Laursen, MSc, PhD, Maria Rodrigo-Domingo, Sara Correia Marques, Sophie Bech Rasmussen, Mette Nyegaard, PhD, Michael Gaihede, MD PhD, Michael B. Møller, MD DMSc, Richard Samworth, Rajen Shah, Preben Johansen, Tarec Christoffer El-Galaly, Ken H. Young, MD PhD, Hans Erik Johnsen
Journal: Blood
Blood (2014) 124 (21): 2973.
https://doi.org/10.1182/blood.V124.21.2973.2973
Published: 2014
Journal Articles

Akt Activation Confers an Inferior Survival in Patients with Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Qi Shen, Zijun Yidan Xu-Monette, PhD, Ganiraju Manyam, Carlo Visco, Alexander Tzankov, MD PhD, Xin Cao, Lijuan Deng, Santiago Montes-Moreno, MD PhD, Karen Dybkær, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD PhD, Govind Bhagat, MD, Kristy L. Richards, MDPhD, Eric D. Hsi, MD, William Choi, Joannes H.J.M. Van Krieken, PhDMD, Jooryung Huh, Maurilio Ponzoni, MD, Andres J.M. Ferreri, MD PhD, John P. Farnen, MD, Michael B. Møller, MD DMSc, Jane N. Winter, MD, Miguel Angel A. Piris, MD PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD PhD
Journal: Blood
Blood (2014) 124 (21): 143.
https://doi.org/10.1182/blood.V124.21.143.143
Published: 2014
Journal Articles

Tumor Microenvironmental Features and Outcome in Post-Transplant Lymphoproliferative Disorder

Maja Ølholm Vase, MD, Eva Maksten, MDcal student, Knud Bendix, Stephen Jacques Hamilton-Dutoit, Claus Andersen, Michael B. Møller, MD DMSc, Søren Schwartz Sørensen, Bente Jespersen, MD, Jan Kampmann, Gabriel Rabinovich, PhD, Esben Søndergård, Patricia Switten Nielsen, Francesco d'Amore
Journal: Blood
Blood (2014) 124 (21): 1617.
https://doi.org/10.1182/blood.V124.21.1617.1617
Published: 2014
Journal Articles

NF-κB Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Ling Li, MD, Zijun Yidan Xu-Monette, PhD, Chi Young Ok, MD, Alexander Tzanko, Carlo Visco, Nora Gisin, Santiago Montes-Moreno, MD PhD, Karen Dybkær, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD PhD, Govind Bhagat, MD, Kristy L. Richards, MDPhD, Eric D. Hsi, MD, William W. L. Choi, MD PhD, Joannes H.J.M. Van Krieken, PhDMD, Jooryung Huh, Maurilio Ponzoni, Andres J.M. Ferreri, MD PhD, Michael B. Møller, MD DMSc, Ronald S. Go, MD, Jane N. Winter, MD, Miguel A. Piris, MD PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1620.
https://doi.org/10.1182/blood.V124.21.1620.1620
Published: 2014
Journal Articles

Diffuse Large B-Cell Lymphoma With Combined TP53 mutation and MIR34A methylation: Another “double hit” Lymphoma With Very Poor Outcome?

Fazila Asmar, MD, Christoffer Hother, MD, PhD, Gorjan Kulosman, MD, Marianne B. Treppendahl, MD PhD, Helene Myrtue Nielsen, MSc, Ralfkiaer Ulrik, MSc, Anja Pedersen, Michael B. Møller, MD, DMSc, Elisabeth Ralfkiaer, MD, DMSc, Peter de Nully Brown, MD, Kirsten Grønbæk, MD, DMSc
Journal: Blood
Blood (2013) 122 (21): 83.
https://doi.org/10.1182/blood.V122.21.83.83
Published: 2013
Journal Articles

miR34s in Normal and Malignant B-Cells: miR34A Plays a Dominant Role in Normal B-Cells, and aggressive Diffuse Large B-Cell Lymphoma Carry Combined Lesions of TP53, MIR34A , and MIR34B/C

Christoffer Hother, MD, Fazila Asmar, MD, Gorjan Kulosman, MD, Marianne B. Treppendahl, MD, Ditte Reker, Ulrik Ralfkiaer, MSc, Anja Pedersen, Michael B. Møller, MD, DMSc, Peter De Nully Brown, Kirsten Grønbæk, MD, DMSc
Journal: Blood
Blood (2012) 120 (21): 296.
https://doi.org/10.1182/blood.V120.21.296.296
Published: 2012
Journal Articles

A New Simplified Prognostic Index with Age Cut-off of 70 Years for Patients with Diffuse Large B-Cell Lymphoma. A Population-Based Analysis From the Danish Lymphoma Registry, LYFO

Anne Ortved Gang, Michael Pedersen, MD, Francesco d'Amore, Lars Møller-Pedersen, MD, PhD, Bo Amdi Pedersen, Paw Jensen, Bjarne Bach Pedersen, Michael B. Møller, MD, DMSc, Ole Gadeberg, Steen Ingeberg, Torben mourits-Andersen, MD, Stanislaw Pulczynski, Tobias Wirenfeldt Klausen, Peter De Nully Brown
Journal: Blood
Blood (2012) 120 (21): 3651.
https://doi.org/10.1182/blood.V120.21.3651.3651
Published: 2012
Journal Articles

Prognostic Significance and Phenotypic Manifestations of MYC/BCL2 Protein Expression in Diffuse Large B-Cell Lymphoma (DLBCL) with Extranodal Organ Involvement: A Report of the International DLBCL Rituximab-CHOP Consortium Program Study

Anusha Madadi, MD, Meghana Raghavendra, MD, Shimin Hu, Zijun Y. Xu-Monette, PhD, Carlo Visco, MD, Alexander Tzankov, MD, Santiago Montes-Moreno, MD, Karen Dybkaer, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, Cherie H. Dunphy, MD, Eric D. Hsi, MD, Frank X. Zhao, MD, PhD, William W. L. Choi, MD, Xiaoying Zhao, MD, Joannes H.J.M. Van Krieken, PhD, MD, Jooryung Huh, MD, Qin Huang, MD, PhD, Wei Ai, MD, Maurilio Ponzoni, Andrés J.M. Ferreri, MD, Fan Zhou, MD, PhD, Jane N. Winter, MD, Miguel Piris, MD, Michael B. Møller, MD, DMSc, L. Jeffrey Medeiros, MD, Ronald S. Go, MD, Ken H. Young, MD
Journal: Blood
Blood (2012) 120 (21): 544.
https://doi.org/10.1182/blood.V120.21.544.544
Published: 2012
Journal Articles

miRNA Profiling Predicts Survival and Identifies a Novel Putative Oncomir in Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy

Christoffer Hother, MD, Ditte Reker, Konstantions Dimopoulos, MD, Steen Knudsen, PhD, Thomas Jensen, Michael B. Møller, MD, DMSc, Peter De Nully Brown, Elisabeth Ralfkiaer, Prof., MD, DMSc, Kirsten Grønbæk, MD, DMSc
Journal: Blood
Blood (2012) 120 (21): 1548.
https://doi.org/10.1182/blood.V120.21.1548.1548
Published: 2012
Journal Articles

Mutation in the Nucleophosmin Gene (NPM1) Is a Stable Marker for Minimal Residual Disease Monitoring in Acute Myeloid Leukemia Patients with Increased Sensitivity and Specificity Compared to Expression of the Wilms Tumor (WT1) Gene.

Thomas Kristensen, PhD, Birgitte Strange Preiss, MD, Lone Friis, MD, PhD, Michael B. Møller, MD, DMSc
Journal: Blood
Blood (2009) 114 (22): 1602.
https://doi.org/10.1182/blood.V114.22.1602.1602
Published: 2009
Journal Articles

Mantle Cell Lymphoma: Prognostic Capacity of the Follicular Lymphoma International Prognostic Index.

Michael B. Moller, MD, DMSc, Niels T. Pedersen, MD, DMSc, Bjarne E. Christensen, MD, DMSC
Journal: Blood
Blood (2005) 106 (11): 1910.
https://doi.org/10.1182/blood.V106.11.1910.1910
Published: 2005
Journal Articles

Conditional Survival of Patients with Diffuse Large B-Cell Lymphoma.

Michael B. Moller, MD, DMSc, Niels T. Pedersen, MD, DMSc, Bjarne E. Christensen, MD, DMSc
Journal: Blood
Blood (2005) 106 (11): 1911.
https://doi.org/10.1182/blood.V106.11.1911.1911
Published: 2005
Journal Articles

Molecular and Clinical Features of Diffuse Large B-Cell Lymphoma with MYC Alterations: Inverse Correlation with p53 Pathway Disruption.

Michael B. Moller, MD, DMSc, Ole Nielsen, Bjarne E. Christensen, MD, DMSc, Niels T. Pedersen
Journal: Blood
Blood (2005) 106 (11): 1912.
https://doi.org/10.1182/blood.V106.11.1912.1912
Published: 2005